Dr. Woodrow has focused her research at the interface of biomaterials engineering and mucosal biology, where her lab has developed several platform technologies for mucosal delivery of therapeutics. Based on fundamental understanding of viral pathogenesis and host PK/PD and immunity, her lab has innovated across diverse polymeric material delivery platforms to develop new sustained release formulations for antiviral drugs and new approaches for mucosal vaccination. Her laboratory’s interests are in (1) combination drug/biologic delivery in HIV prevention, treatment and cure; (2) vaccine delivery to investigate and elicit mucosal immunity, and (3) novel drug-device and other integrated systems for multipurpose prevention of sexually transmitted infections and unintended pregnancy.
Kim A. Woodrow is an Associate Professor in the Department of Bioengineering at the University of Washington. She earned her MS and PhD degrees from Stanford in Chemical Engineering. From 2006-2009, Dr. Woodrow was a postdoctoral fellow in Biomedical Engineering at Yale University. Since joining UW Bioengineering in 2010, Dr. Woodrow’s research interests have focused on applications at the intersection of engineering and mucosal biology, where her lab works on the design and synthesis of biomaterials for applications in mucosal infections and mucosal immunity. Dr. Woodrow is an NIH-funded investigator, the recipient of the Creative and Novel Ideas in HIV Research (CNIHR) award from the Office of AIDS Research, a recipient of grants from The Bill and Melinda Gates Foundation, and was awarded a NIH Director’s New Innovator Award. She has served as a member of the NIH-NANO study section, and on the technical program committees for BMES and the international HIV R4P conference. She has been recognized with the University of Washington FACET Award, Undergraduate Research Mentor Award and as the Science in Medicine New Investigator for the School of Medicine.